Home
About
- About Molecure S.A.
- Our Team
R&D
Research Partnerships
- In-licensing
- Commercial Partnership
Investors
News & Events
- Press Releases
- Events & Presentations
Careers
Contact

Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis

About us

Molecure is an innovative biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.

This site is registered on wpml.org as a development site.